- Resource
- BR1DGE
Module 5: The Current and Emerging Management of Autoimmune Type 1 Diabetes
This module explores current evidence-based management approaches for T1D and examines emerging therapeutic strategies that may modify the course of T1D
Chapter 5.1: Current and Emerging Management Options for Type 1 Diabetes
This chapter will explore current and emerging therapies and the fundamental principles of insulin management.
Learning Objectives
- Understand the impact of health inequities on DKA presentation at T1D diagnosis
- Recognize that advances in insulin delivery technology have not fully translated into improved population-level glycemic outcomes for people with T1D
- Identify the daily demands of T1D management beyond device use, including the continuous decision-making required around diet, activity and daily life
Learning Objectives
- Recognize insulin replacement therapy treats the symptoms of T1D but does not eliminate the burden
- Highlight that several investigational immunotherapies disease-modifying therapies (DMTs) in Phase 2 and Phase 3 development have shown the ability to significantly preserve beta-cell function in recent-onset Stage 3 T1D
- Understand how the future of T1D care looks to shift focus from insulin therapy to preserving beta cells
5.2 Taking Control of Your T1D
This chapter will explore the importance of clear communication towards individuals affected by T1D, discussing the role of social media, healthy behaviors and options for self-management in order for individuals to "take control of their T1D".
Learning Objectives
- Understand the role of TCOYD in improving outcomes for individuals with T1D
- Explore the evolving role of social media in diabetes education and outreach in the post-COVID era
Learning Objective
- Recognize how clear communication with children with T1D and their caregivers can help convey progression risk and the value of healthy behaviors towards self-management
Congratulations on completing BR1DGE Module 5: The Current and Emerging Management of Autoimmune Type 1 Diabetes!
Monitoring Type one diabetes progressions
This module will describe recommended guidance for and emphasize the importance of monitoring disease progression in individuals where IAbs have been detected.
The module also focuses on the potential of C-peptide as a tool to aid diagnostics and as a prognostic tool in monitoring. Finally, the module explores the psychosocial support and education of individuals undergoing T1D monitoring.
Pathophisiology and stages of T1D
This module delves into the underlying biological mechanisms and causes of T1D, explaining how the disease develops
Early detection of autoimmune type 1 diabetes
This module focuses on methods and strategies for identifying T1D in its presymptomatic stages, emphasizing the benefits of early diagnosis